CRISPR & Sickle Cell

Last summer, doctors in Tennessee injected Victoria Gray—a 34-year-old sickle cell disease patient —with billions of her own stem cells that scientists in Massachusetts had reprogrammed with Crispr to produce healthy blood cells. The hours-long infusion made her the first American with a heritable disease to be treated with the experimental gene-editing technology. And it appears to be working.